AMETEK is a U.S.-based industrial manufacturer that makes highly specialized electronic instruments and electromechanical devices. The company operates through two segments: the Electronic Instruments Group (EIG, ~62% of sales) and the Electromechanical Group (EMG, ~38% of sales). EIG designs and manufactures process analyzers, pressure and temperature sensors, aerospace sensors, power quality monitoring equipment, and ultra-precision metrology systems. EMG makes precision motion control solutions, single-use surgical instruments, implantable components, drug delivery devices, thermal management systems, and specialty metals, and also operates a global aviation MRO network. AMETEK sells primarily through a direct sales force to industrial manufacturers, aerospace OEMs, pharmaceutical companies, medical device OEMs, utilities, and research institutions. Because AMETEK's products are mission-critical and embedded in customers' processes, aircraft systems, or medical procedures, customers prioritize performance and reliability over price, giving AMETEK meaningful pricing power and high switching costs. M&A is a core earnings driver: AMETEK systematically acquires niche businesses with strong technology but undermanaged operations, integrates them into its business system, and expands EBITDA margins from the mid-teens to ~30% over two to three years. The business is asset-light, with capex running at ~2% of sales, and generates free cash flow that consistently exceeds net income, financing the acquisition engine. AMETEK operates a decentralized model, with individual business units run as standalone P&Ls.